These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 17154505)
1. Flavonoid dimers as bivalent modulators for P-glycoprotein-based multidrug resistance: synthetic apigenin homodimers linked with defined-length poly(ethylene glycol) spacers increase drug retention and enhance chemosensitivity in resistant cancer cells. Chan KF; Zhao Y; Burkett BA; Wong IL; Chow LM; Chan TH J Med Chem; 2006 Nov; 49(23):6742-59. PubMed ID: 17154505 [TBL] [Abstract][Full Text] [Related]
2. Flavonoid dimers as bivalent modulators for p-glycoprotein-based multidrug resistance: structure-activity relationships. Chan KF; Zhao Y; Chow TW; Yan CS; Ma DL; Burkett BA; Wong IL; Chow LM; Chan TH ChemMedChem; 2009 Apr; 4(4):594-614. PubMed ID: 19288491 [TBL] [Abstract][Full Text] [Related]
3. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance. Newman MJ; Rodarte JC; Benbatoul KD; Romano SJ; Zhang C; Krane S; Moran EJ; Uyeda RT; Dixon R; Guns ES; Mayer LD Cancer Res; 2000 Jun; 60(11):2964-72. PubMed ID: 10850444 [TBL] [Abstract][Full Text] [Related]
4. Reversal of cancer multidrug resistance by green tea polyphenols. Mei Y; Qian F; Wei D; Liu J J Pharm Pharmacol; 2004 Oct; 56(10):1307-14. PubMed ID: 15482646 [TBL] [Abstract][Full Text] [Related]
5. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol. Arora A; Seth K; Kalra N; Shukla Y Toxicol Appl Pharmacol; 2005 Feb; 202(3):237-43. PubMed ID: 15667829 [TBL] [Abstract][Full Text] [Related]
6. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells. Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169 [TBL] [Abstract][Full Text] [Related]
7. Design and syntheses of permethyl ningalin B analogues: potent multidrug resistance (MDR) reversal agents of cancer cells. Zhang PY; Wong IL; Yan CS; Zhang XY; Jiang T; Chow LM; Wan SB J Med Chem; 2010 Jul; 53(14):5108-20. PubMed ID: 20560605 [TBL] [Abstract][Full Text] [Related]
8. Amine linked flavonoid dimers as modulators for P-glycoprotein-based multidrug resistance: structure-activity relationship and mechanism of modulation. Chan KF; Wong IL; Kan JW; Yan CS; Chow LM; Chan TH J Med Chem; 2012 Mar; 55(5):1999-2014. PubMed ID: 22320402 [TBL] [Abstract][Full Text] [Related]
9. CJY, an isoflavone, reverses P-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukaemia (K562/DOX) cells. Ji BS; He L J Pharm Pharmacol; 2007 Jul; 59(7):1011-5. PubMed ID: 17637197 [TBL] [Abstract][Full Text] [Related]
10. Characterization of 2-chloro-N10-substituted phenoxazines for reversing multidrug resistance in cancer cells. Thimmaiah KN; Jayashree BS; Germain GS; Houghton PJ; Horton JK Oncol Res; 1998; 10(1):29-41. PubMed ID: 9613455 [TBL] [Abstract][Full Text] [Related]
11. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells. Wang TX; Yang XH Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331 [TBL] [Abstract][Full Text] [Related]
12. Control of P-glycoprotein activity by membrane cholesterol amounts and their relation to multidrug resistance in human CEM leukemia cells. Gayet L; Dayan G; Barakat S; Labialle S; Michaud M; Cogne S; Mazane A; Coleman AW; Rigal D; Baggetto LG Biochemistry; 2005 Mar; 44(11):4499-509. PubMed ID: 15766280 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel. Zhu X; Sui M; Fan W Anticancer Res; 2005; 25(3B):1953-62. PubMed ID: 16158930 [TBL] [Abstract][Full Text] [Related]
14. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models. Peer D; Dekel Y; Melikhov D; Margalit R Cancer Res; 2004 Oct; 64(20):7562-9. PubMed ID: 15492283 [TBL] [Abstract][Full Text] [Related]
15. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo. Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326 [TBL] [Abstract][Full Text] [Related]
16. Poly(ethylene glycol)-conjugated multi-walled carbon nanotubes as an efficient drug carrier for overcoming multidrug resistance. Cheng J; Meziani MJ; Sun YP; Cheng SH Toxicol Appl Pharmacol; 2011 Jan; 250(2):184-93. PubMed ID: 20970441 [TBL] [Abstract][Full Text] [Related]
17. Reversal of P-glycoprotein-mediated multidrug resistance by Alisol B 23-acetate. Wang C; Zhang JX; Shen XL; Wan CK; Tse AK; Fong WF Biochem Pharmacol; 2004 Sep; 68(5):843-55. PubMed ID: 15294447 [TBL] [Abstract][Full Text] [Related]
18. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux. Chavanpatil MD; Patil Y; Panyam J Int J Pharm; 2006 Aug; 320(1-2):150-6. PubMed ID: 16713148 [TBL] [Abstract][Full Text] [Related]
19. Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice. Chou TC; Guan Y; Soenen DR; Danishefsky SJ; Boger DL Cancer Chemother Pharmacol; 2005 Oct; 56(4):379-90. PubMed ID: 15875185 [TBL] [Abstract][Full Text] [Related]
20. P-glycoprotein expression induced by glucose depletion enhanced the chemosensitivity in human hepatocellular carcinoma cell-lines. Cheng SC; Zhou J; Xie Y Cell Biol Int; 2005 Apr; 29(4):269-75. PubMed ID: 15914037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]